TreeWAS – Variant ID: rs2547231

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
K80.2 Calculus of gallbladder without cholecystitis	1.000	0.000	0.000
K80.1 Calculus of gallbladder with other cholecystitis	1.000	0.000	0.000
K80 Cholelithiasis	1.000	0.000	0.000
K82 Other diseases of gallbladder	1.000	0.000	0.000
K80-K87 Disorders of gallbladder, biliary tract and pancreas	1.000	0.000	0.000
K82.8 Other specified diseases of gallbladder	0.996	0.004	0.000
K80.5 Calculus of bile duct without cholangitis or cholecystitis	0.989	0.011	0.000
K82.4 Cholesterolosis of gallbladder	0.974	0.026	0.000
K82.9 Disease of gallbladder, unspecified	0.958	0.042	0.000
K81 Cholecystitis	0.936	0.064	0.000
K82.2 Perforation of gallbladder	0.875	0.125	0.000
K81.9 Cholecystitis, unspecified	0.851	0.149	0.000
K83 Other diseases of biliary tract	0.827	0.173	0.000
K80.0 Calculus of gallbladder with acute cholecystitis	0.816	0.184	0.000
K80.4 Calculus of bile duct with cholecystitis	0.816	0.184	0.000
K81.0 Acute cholecystitis	0.787	0.213	0.000
K82.0 Obstruction of gallbladder	0.783	0.217	0.000
K82.1 Hydrops of gallbladder	0.763	0.237	0.000
K82.3 Fistula of gallbladder	0.758	0.242	0.000
K83.8 Other specified diseases of biliary tract	0.725	0.275	0.000
K80.3 Calculus of bile duct with cholangitis	0.717	0.283	0.000
K87 Disorders of gallbladder, biliary tract and pancreas in diseases classified elsewhere	0.717	0.283	0.000
K83.4 Spasm of sphincter of Oddi	0.685	0.315	0.000
K81.1 Chronic cholecystitis	0.684	0.316	0.000
K81.8 Other cholecystitis	0.669	0.331	0.000
K83.9 Disease of biliary tract, unspecified	0.665	0.335	0.000
K83.3 Fistula of bile duct	0.614	0.386	0.000
K83.2 Perforation of bile duct	0.580	0.420	0.000
K80.8 Other cholelithiasis	0.526	0.473	0.000
K83.1 Obstruction of bile duct	0.514	0.486	0.000
K80.36 Calculus of bile duct with acute and chronic cholangitis without obstruction	0.514	0.486	0.000
K87.1 Disorders of pancreas in diseases classified elsewhere	0.514	0.486	0.000
K87.0 Disorders of gallbladder and biliary tract in diseases classified elsewhere	0.514	0.486	0.000
K83.5 Biliary cyst	0.503	0.497	0.000
K83.0 Cholangitis	0.446	0.554	0.000
K85 Acute pancreatitis	0.391	0.609	0.000
K85.0 Idiopathic acute pancreatitis	0.295	0.705	0.000
K85.1 Biliary acute pancreatitis	0.295	0.705	0.000
K85.8 Other acute pancreatitis	0.265	0.735	0.000
K85.3 Drug-induced acute pancreatitis	0.262	0.737	0.000
K85.9 Acute pancreatitis, unspecified	0.179	0.821	0.000
K86 Other diseases of pancreas	0.177	0.823	0.000
K85.2 Alcohol-induced acute pancreatitis	0.165	0.834	0.001
K86.2 Cyst of pancreas	0.128	0.872	0.000
K86.3 Pseudocyst of pancreas	0.120	0.880	0.000
K86.9 Disease of pancreas, unspecified	0.119	0.881	0.000
K86.0 Alcohol-induced chronic pancreatitis	0.104	0.896	0.000
K86.8 Other specified diseases of pancreas	0.054	0.946	0.000
K26.9 Unspecified as acute or chronic, without haemorrhage or perforation	0.000	0.947	0.053
K86.1 Other chronic pancreatitis	0.046	0.954	0.000
K26 Duodenal ulcer	0.000	0.978	0.022
K26.0 Acute with haemorrhage	0.000	0.980	0.020
K26.7 Chronic without haemorrhage or perforation	0.000	0.981	0.019
K26.1 Acute with perforation	0.000	0.982	0.018
K26.2 Acute with both haemorrhage and perforation	0.000	0.983	0.017
E16.2 Hypoglycaemia, unspecified	0.000	0.983	0.017
K26.5 Chronic or unspecified with perforation	0.000	0.983	0.017
K26.6 Chronic or unspecified with both haemorrhage and perforation	0.000	0.985	0.015
N89.8 Other specified noninflammatory disorders of vagina	0.014	0.986	0.000
K29.5 Chronic gastritis, unspecified	0.014	0.986	0.000
N89 Other noninflammatory disorders of vagina	0.013	0.987	0.000
N89.5 Stricture and atresia of vagina	0.013	0.987	0.000
L81.4 Other melanin hyperpigmentation	0.000	0.987	0.013
N89.6 Tight hymenal ring	0.012	0.988	0.000
N89.9 Noninflammatory disorder of vagina, unspecified	0.011	0.989	0.000
E16 Other disorders of pancreatic internal secretion	0.000	0.989	0.011
N89.1 Moderate vaginal dysplasia	0.010	0.990	0.000
N89.3 Dysplasia of vagina, unspecified	0.010	0.990	0.000
N89.4 Leukoplakia of vagina	0.010	0.990	0.000
N89.0 Mild vaginal dysplasia	0.010	0.990	0.000
N89.7 Haematocolpos	0.010	0.990	0.000
N89.2 Severe vaginal dysplasia, not elsewhere classified	0.010	0.990	0.000
E16.0 Drug-induced hypoglycaemia without coma	0.000	0.991	0.009
E16.9 Disorder of pancreatic internal secretion, unspecified	0.000	0.992	0.008
E16.8 Other specified disorders of pancreatic internal secretion	0.000	0.992	0.008
E16.4 Abnormal secretion of gastrin	0.000	0.992	0.008
E16.3 Increased secretion of glucagon	0.000	0.992	0.008
Z63.4 Disappearance and death of family member	0.008	0.992	0.000
K26.4 Chronic or unspecified with haemorrhage	0.000	0.992	0.008
E16.1 Other hypoglycaemia	0.000	0.992	0.008
Z63 Other problems related to primary support group, including family circumstances	0.007	0.993	0.000
Z63.0 Problems in relationship with spouse or partner	0.007	0.993	0.000
Z63.5 Disruption of family by separation and divorce	0.006	0.994	0.000
Z63.7 Other stressful life events affecting family and household	0.006	0.994	0.000
Z63.6 Dependent relative needing care at home	0.006	0.994	0.000
C77.1 Intrathoracic lymph nodes	0.000	0.994	0.006
Z63.9 Problem related to primary support group, unspecified	0.005	0.995	0.000
Z63.3 Absence of family member	0.005	0.995	0.000
Z63.2 Inadequate family support	0.005	0.995	0.000
Z63.1 Problems in relationship with parents and in-laws	0.005	0.995	0.000
K26.3 Acute without haemorrhage or perforation	0.001	0.995	0.004
Z63.8 Other specified problems related to primary support group	0.005	0.995	0.000
D36.1 Peripheral nerves and autonomic nervous system	0.005	0.995	0.000
Z48.8 Other specified surgical follow-up care	0.000	0.995	0.005
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion	0.000	0.995	0.005
E21.0 Primary hyperparathyroidism	0.000	0.996	0.004
M79.54 Residual foreign body in soft tissue (Hand)	0.000	0.996	0.004
L50.0 Allergic urticaria	0.000	0.996	0.004
D17.5 Benign lipomatous neoplasm of intra-abdominal organs	0.000	0.996	0.004
T50.9 Other and unspecified drugs, medicaments and biological substances	0.000	0.996	0.004
Z29.2 Other prophylactic chemotherapy	0.000	0.996	0.004
E15 Nondiabetic hypoglycaemic coma	0.000	0.996	0.004
N03.9 Unspecified	0.003	0.997	0.000
N62 Hypertrophy of breast	0.000	0.997	0.003
F52.2 Failure of genital response	0.003	0.997	0.000
F80.1 Expressive language disorder	0.000	0.997	0.003
O80.9 Single spontaneous delivery, unspecified	0.000	0.997	0.003
K46.9 Unspecified abdominal hernia without obstruction or gangrene	0.000	0.997	0.003
F43.2 Adjustment disorders	0.000	0.997	0.003
Z29.8 Other specified prophylactic measures	0.000	0.997	0.003
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.997	0.003
Z29 Need for other prophylactic measures	0.000	0.997	0.003
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.000	0.998	0.002
Z29.1 Prophylactic immunotherapy	0.000	0.998	0.002
E21 Hyperparathyroidism and other disorders of parathyroid gland	0.000	0.998	0.002
T50.4 Drugs affecting uric acid metabolism	0.000	0.998	0.002
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.000	0.998	0.002
F32.3 Severe depressive episode with psychotic symptoms	0.000	0.998	0.002
E21.3 Hyperparathyroidism, unspecified	0.000	0.998	0.002
M24.16 Other articular cartilage disorders (Lower leg)	0.002	0.998	0.000
T50.1 Loop [high-ceiling] diuretics	0.000	0.998	0.002
T50.6 Antidotes and chelating agents, not elsewhere classified	0.000	0.998	0.002
T50.7 Analeptics and opioid receptor antagonists	0.000	0.998	0.002
T50.5 Appetite depressants	0.000	0.998	0.002
T50.3 Electrolytic, caloric and water-balance agents	0.000	0.998	0.002
T50.0 Mineralocorticoids and their antagonists	0.000	0.998	0.002
Z29.9 Prophylactic measure, unspecified	0.000	0.998	0.002
T92.8 Sequelae of other specified injuries of upper limb	0.002	0.998	0.000
L81 Other disorders of pigmentation	0.000	0.998	0.002
D22.7 Melanocytic naevi of lower limb, including hip	0.002	0.998	0.000
E21.5 Disorder of parathyroid gland, unspecified	0.000	0.998	0.002
K63.3 Ulcer of intestine	0.002	0.998	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.000	0.998	0.002
O82.0 Delivery by elective Caesarean section	0.000	0.998	0.002
F80 Specific developmental disorders of speech and language	0.000	0.998	0.002
E14.3 With ophthalmic complications	0.000	0.998	0.002
N03 Chronic nephritic syndrome	0.002	0.998	0.000
F80.2 Receptive language disorder	0.000	0.998	0.002
T39.0 Salicylates	0.000	0.998	0.002
M18.1 Other primary arthrosis of first carpometacarpal joint	0.000	0.998	0.002
E21.1 Secondary hyperparathyroidism, not elsewhere classified	0.000	0.998	0.002
O68.0 Labour and delivery complicated by foetal heart rate anomaly	0.000	0.998	0.002
T50.8 Diagnostic agents	0.000	0.998	0.002
F32.2 Severe depressive episode without psychotic symptoms	0.002	0.998	0.000
D63.8 Anaemia in other chronic diseases classified elsewhere	0.000	0.998	0.002
E21.4 Other specified disorders of parathyroid gland	0.000	0.998	0.002
F10.2 Dependence syndrome	0.000	0.998	0.002
O99.0 Anaemia complicating pregnancy, childbirth and the puerperium	0.000	0.998	0.002
F52 Sexual dysfunction, not caused by organic disorder or disease	0.002	0.998	0.000
F11.0 Acute intoxication	0.000	0.998	0.002
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.998	0.002
E21.2 Other hyperparathyroidism	0.000	0.998	0.002
O82.1 Delivery by emergency Caesarean section	0.000	0.998	0.002
T92.6 Sequelae of crushing injury and traumatic amputation of upper limb	0.002	0.998	0.000
Y04.8 Other specified place	0.002	0.998	0.000
S06.30 Focal brain injury (without open intracranial wound)	0.000	0.998	0.002
F05.9 Delirium, unspecified	0.000	0.998	0.002
T92.5 Sequelae of injury of muscle and tendon of upper limb	0.002	0.998	0.000
F11 Mental and behavioural disorders due to use of opioids	0.000	0.998	0.002
L81.6 Other disorders of diminished melanin formation	0.000	0.998	0.002
L81.5 Leukoderma, not elsewhere classified	0.000	0.998	0.002
L81.3 Cafe au lait spots	0.000	0.998	0.002
L81.1 Chloasma	0.000	0.998	0.002
N03.5 Diffuse mesangiocapillary glomerulonephritis	0.002	0.998	0.000
T39.1 4-Aminophenol derivatives	0.000	0.998	0.002
F11.3 Withdrawal state	0.000	0.998	0.002
F80.9 Developmental disorder of speech and language, unspecified	0.000	0.998	0.002
F80.8 Other developmental disorders of speech and language	0.000	0.998	0.002
F80.3 Acquired aphasia with epilepsy [Landau-Kleffner]	0.000	0.998	0.002
F80.0 Specific speech articulation disorder	0.000	0.998	0.002
T39.4 Antirheumatics, not elsewhere classified	0.000	0.998	0.002
T39.2 Pyrazolone derivatives	0.000	0.998	0.002
L81.0 Postinflammatory hyperpigmentation	0.000	0.998	0.002
N03.8 Other	0.002	0.998	0.000
F41.0 Panic disorder [episodic paroxysmal anxiety]	0.002	0.998	0.000
N03.2 Diffuse membranous glomerulonephritis	0.002	0.998	0.000
Y04.2 School, other institution and public administrative area	0.002	0.998	0.000
T92 Sequelae of injuries of upper limb	0.002	0.998	0.000
F11.2 Dependence syndrome	0.000	0.998	0.002
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.998	0.002
N90.4 Leukoplakia of vulva	0.000	0.998	0.002
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.000	0.998	0.002
T93.2 Sequelae of other fractures of lower limb	0.002	0.998	0.000
F11.1 Harmful use	0.000	0.998	0.002
N03.7 Diffuse crescentic glomerulonephritis	0.002	0.998	0.000
N03.6 Dense deposit disease	0.002	0.998	0.000
N03.4 Diffuse endocapillary proliferative glomerulonephritis	0.002	0.998	0.000
N03.3 Diffuse mesangial proliferative glomerulonephritis	0.002	0.998	0.000
N03.0 Minor glomerular abnormality	0.002	0.998	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.000	0.998	0.002
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.000	0.998	0.002
T91.9 Sequelae of unspecified injury of neck and trunk	0.002	0.998	0.000
M24.11 Other articular cartilage disorders (Shoulder region)	0.002	0.998	0.000
I81 Portal vein thrombosis	0.000	0.998	0.002
O82 Single delivery by Caesarean section	0.000	0.998	0.002
M24.13 Other articular cartilage disorders (Forearm)	0.002	0.998	0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.000	0.998	0.002
L81.7 Pigmented purpuric dermatosis	0.000	0.998	0.001
L81.2 Freckles	0.000	0.998	0.001
D36 Benign neoplasm of other and unspecified sites	0.002	0.998	0.000
Y04 Assault by bodily force	0.002	0.998	0.000
D10.3 Other and unspecified parts of mouth	0.002	0.998	0.000
F12.1 Harmful use	0.000	0.998	0.002
F52.9 Unspecified sexual dysfunction, not caused by organic disorder or disease	0.001	0.998	0.000
F52.8 Other sexual dysfunction, not caused by organic disorder or disease	0.001	0.998	0.000
F52.7 Excessive sexual drive	0.001	0.998	0.000
F52.6 Nonorganic dyspareunia	0.001	0.998	0.000
F52.5 Nonorganic vaginismus	0.001	0.998	0.000
F52.4 Premature ejaculation	0.001	0.998	0.000
F52.3 Orgasmic dysfunction	0.001	0.998	0.000
F52.1 Sexual aversion and lack of sexual enjoyment	0.001	0.998	0.000
F52.0 Lack or loss of sexual desire	0.001	0.998	0.000
I07.1 Tricuspid insufficiency	0.000	0.998	0.002
M24.1 Other articular cartilage disorders	0.002	0.998	0.000
N03.1 Focal and segmental glomerular lesions	0.001	0.998	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.998	0.002
T92.4 Sequelae of injury of nerve of upper limb	0.002	0.998	0.000
T91.3 Sequelae of injury of spinal cord	0.002	0.998	0.000
F11.9 Unspecified mental and behavioural disorder	0.000	0.998	0.001
F11.8 Other mental and behavioural disorders	0.000	0.998	0.001
F11.7 Residual and late-onset psychotic disorder	0.000	0.998	0.001
F11.6 Amnesic syndrome	0.000	0.998	0.001
F11.5 Psychotic disorder	0.000	0.998	0.001
F11.4 Withdrawal state with delirium	0.000	0.998	0.001
L81.8 Other specified disorders of pigmentation	0.000	0.998	0.001
T88.7 Unspecified adverse effect of drug or medicament	0.002	0.998	0.000
O32.0 Maternal care for unstable lie	0.000	0.998	0.002
S83.2 Tear of meniscus, current	0.002	0.998	0.000
D36.0 Lymph nodes	0.001	0.998	0.000
T93.3 Sequelae of dislocation, sprain and strain of lower limb	0.002	0.998	0.000
Y04.3 Sports and athletics area	0.001	0.998	0.000
S06.20 Diffuse brain injury (without open intracranial wound)	0.000	0.998	0.001
S39.9 Unspecified injury of abdomen, lower back and pelvis	0.002	0.998	0.000
T91 Sequelae of injuries of neck and trunk	0.002	0.998	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.998	0.001
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.998	0.001
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.998	0.001
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.998	0.001
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.998	0.001
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.998	0.001
T44.0 Anticholinesterase agents	0.000	0.998	0.001
T47.0 Histamine H(2)-receptor antagonists	0.000	0.998	0.001
L50 Urticaria	0.000	0.998	0.001
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.998	0.001
M24.51 Contracture of joint (Shoulder region)	0.001	0.998	0.000
C91.1 Chronic lymphocytic leukaemia	0.001	0.998	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.000	0.998	0.001
Z29.0 Isolation	0.000	0.998	0.001
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.000	0.999	0.001
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.999	0.001
Y04.9 Unspecified place	0.001	0.999	0.000
Z48 Other surgical follow-up care	0.000	0.999	0.001
F10.5 Psychotic disorder	0.000	0.999	0.001
O82.8 Other single delivery by Caesarean section	0.000	0.999	0.001
O82.2 Delivery by Caesarean hysterectomy	0.000	0.999	0.001
T91.8 Sequelae of other specified injuries of neck and trunk	0.001	0.999	0.000
Z48.0 Attention to surgical dressings and sutures	0.000	0.999	0.001
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.999	0.001
T47.6 Antidiarrhoeal drugs	0.000	0.999	0.001
T93.9 Sequelae of unspecified injury of lower limb	0.001	0.999	0.000
Y04.4 Street and highway	0.001	0.999	0.000
Y04.0 Home	0.001	0.999	0.000
Y04.7 Farm	0.001	0.999	0.000
Y04.6 Industrial and construction area	0.001	0.999	0.000
Y04.5 Trade and service area	0.001	0.999	0.000
Y04.1 Residential institution	0.001	0.999	0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.001	0.999	0.000
G08 Intracranial and intraspinal phlebitis and thrombophlebitis	0.001	0.999	0.000
M24.19 Other articular cartilage disorders (Site unspecified)	0.001	0.999	0.000
M24.18 Other articular cartilage disorders (Other)	0.001	0.999	0.000
M24.14 Other articular cartilage disorders (Hand)	0.001	0.999	0.000
M24.12 Other articular cartilage disorders (Upper arm)	0.001	0.999	0.000
M24.10 Other articular cartilage disorders (Multiple sites)	0.001	0.999	0.000
B18.1 Chronic viral hepatitis B without delta-agent	0.000	0.999	0.001
J38.4 Oedema of larynx	0.000	0.999	0.001
T81.3 Disruption of operation wound, not elsewhere classified	0.000	0.999	0.001
F12 Mental and behavioural disorders due to use of cannabinoids	0.000	0.999	0.001
D14.0 Middle ear, nasal cavity and accessory sinuses	0.001	0.999	0.000
F10 Mental and behavioural disorders due to use of alcohol	0.000	0.999	0.001
N84.2 Polyp of vagina	0.001	0.999	0.000
T92.1 Sequelae of fracture of arm	0.001	0.999	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.999	0.001
T93 Sequelae of injuries of lower limb	0.001	0.999	0.000
M05.99 Seropositive rheumatoid arthritis, unspecified (Site unspecified)	0.000	0.999	0.001
M70.46 Prepatellar bursitis-Lower Leg	0.000	0.999	0.001
N11.9 Chronic tubulo-interstitial nephritis, unspecified	0.000	0.999	0.001
N80.3 Endometriosis of pelvic peritoneum	0.001	0.999	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.999	0.001
Y04.99 Assault by bodily force, Unspecified place, During unspecified	0.001	0.999	0.000
T91.5 Sequelae of injury of intra-abdominal and pelvic organs	0.001	0.999	0.000
T91.4 Sequelae of injury of intrathoracic organs	0.001	0.999	0.000
T91.2 Sequelae of other fracture of thorax and pelvis	0.001	0.999	0.000
T91.0 Sequelae of superficial injury and open wound of neck and trunk	0.001	0.999	0.000
T92.2 Sequelae of fracture at wrist and hand level	0.001	0.999	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.999	0.001
L50.6 Contact urticaria	0.000	0.999	0.001
L50.5 Cholinergic urticaria	0.000	0.999	0.001
L50.4 Vibratory urticaria	0.000	0.999	0.001
L50.3 Dermatographic urticaria	0.000	0.999	0.001
L50.2 Urticaria due to cold and heat	0.000	0.999	0.001
L93.0 Discoid lupus erythematosus	0.001	0.999	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.999	0.001
T47.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.999	0.001
T47.7 Emetics	0.000	0.999	0.001
T47.5 Digestants	0.000	0.999	0.001
T47.3 Saline and osmotic laxatives	0.000	0.999	0.001
T93.6 Sequelae of crushing injury and traumatic amputation of lower limb	0.001	0.999	0.000
W22.9 Unspecified place	0.000	0.999	0.001
F43 Reaction to severe stress, and adjustment disorders	0.000	0.999	0.001
F10.0 Acute intoxication	0.000	0.999	0.001
F12.2 Dependence syndrome	0.000	0.999	0.001
F43.1 Posttraumatic stress disorder	0.000	0.999	0.001
F10.6 Amnesic syndrome	0.000	0.999	0.001
F12.5 Psychotic disorder	0.000	0.999	0.001
F31.2 Bipolar affective disorder, current episode manic with psychotic symptoms	0.001	0.999	0.000
G06.1 Intraspinal abscess and granuloma	0.001	0.999	0.000
M18.0 Primary arthrosis of first carpometacarpal joints, bilateral	0.000	0.999	0.001
T92.9 Sequelae of unspecified injury of upper limb	0.001	0.999	0.000
Z36.8 Other antenatal screening	0.001	0.999	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.999	0.001
M24.15 Other articular cartilage disorders (Pelvic region and thigh)	0.001	0.999	0.000
Y04.09 Assault by bodily force; Home; During unspecified activity	0.001	0.999	0.000
Y04.49 Assault by bodily force; Street and highway; During unspecified activity	0.001	0.999	0.000
Y04.48 Assault by bodily force; Street and highway; While engaged in other specified activities	0.001	0.999	0.000
C84.4 Peripheral T-cell lymphoma	0.000	0.999	0.001
F12.9 Unspecified mental and behavioural disorder	0.000	0.999	0.001
F12.8 Other mental and behavioural disorders	0.000	0.999	0.001
F12.7 Residual and late-onset psychotic disorder	0.000	0.999	0.001
F12.6 Amnesic syndrome	0.000	0.999	0.001
F12.4 Withdrawal state with delirium	0.000	0.999	0.001
F12.3 Withdrawal state	0.000	0.999	0.001
F19.2 Dependence syndrome	0.000	0.999	0.001
M79.57 Residual foreign body in soft tissue (Ankle and foot)	0.000	0.999	0.001
D36.9 Benign neoplasm of unspecified site	0.001	0.999	0.000
F10.9 Unspecified mental and behavioural disorder	0.000	0.999	0.001
T47.4 Other laxatives	0.000	0.999	0.001
T92.0 Sequelae of open wound of upper limb	0.001	0.999	0.000
G06 Intracranial and intraspinal abscess and granuloma	0.001	0.999	0.000
B17.2 Acute hepatitis E	0.000	0.999	0.001
F12.0 Acute intoxication	0.000	0.999	0.001
F31.1 Bipolar affective disorder, current episode manic without psychotic symptoms	0.001	0.999	0.000
G06.2 Extradural and subdural abscess, unspecified	0.001	0.999	0.000
L05.9 Pilonidal cyst without abscess	0.001	0.999	0.000
L50.1 Idiopathic urticaria	0.000	0.999	0.001
O32.2 Maternal care for transverse and oblique lie	0.000	0.999	0.001
T38.0 Glucocorticoids and synthetic analogues	0.000	0.999	0.001
T48.5 Anti-common-cold drugs	0.000	0.999	0.001
T49.9 Topical agent, unspecified	0.000	0.999	0.001
T49.8 Other topical agents	0.000	0.999	0.001
T49.7 Dental drugs, topically applied	0.000	0.999	0.001
T49.6 Otorhinolaryngological drugs and preparations	0.000	0.999	0.001
T49.5 Ophthalmological drugs and preparations	0.000	0.999	0.001
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.999	0.001
T49.3 Emollients, demulcents and protectants	0.000	0.999	0.001
T49.2 Local astringents and local detergents	0.000	0.999	0.001
T49.1 Antipruritics	0.000	0.999	0.001
T92.3 Sequelae of dislocation, sprain and strain of upper limb	0.001	0.999	0.000
T93.4 Sequelae of injury of nerve of lower limb	0.001	0.999	0.000
G09 Sequelae of inflammatory diseases of central nervous system	0.001	0.999	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.999	0.001
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.999	0.001
E03.2 Hypothyroidism due to medicaments and other exogenous substances	0.001	0.999	0.000
F43.9 Reaction to severe stress, unspecified	0.000	0.999	0.001
T38.9 Other and unspecified hormone antagonists	0.000	0.999	0.001
T38.7 Androgens and anabolic congeners	0.000	0.999	0.001
T38.5 Other oestrogens and progestogens	0.000	0.999	0.001
T38.4 Oral contraceptives	0.000	0.999	0.001
T38.2 Antithyroid drugs	0.000	0.999	0.001
T47.2 Stimulant laxatives	0.000	0.999	0.001
O80 Single spontaneous delivery	0.000	0.999	0.001
M25.96 Joint disorder, unspecified (Lower leg)	0.001	0.999	0.000
B17.9 Acute viral hepatitis, unspecified	0.000	0.999	0.001
D38.1 Trachea, bronchus and lung	0.001	0.999	0.000
F10.7 Residual and late-onset psychotic disorder	0.000	0.999	0.001
F43.8 Other reactions to severe stress	0.000	0.999	0.001
L81.9 Disorder of pigmentation, unspecified	0.000	0.999	0.001
M79.5 Residual foreign body in soft tissue	0.000	0.999	0.001
O82.9 Delivery by Caesarean section, unspecified	0.000	0.999	0.001
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.000	0.999	0.001
F19 Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances	0.000	0.999	0.001
M24.02 Loose body in joint (Upper arm)	0.001	0.999	0.000
M24.54 Contracture of joint (Hand)	0.001	0.999	0.000
D03.5 Melanoma in situ of trunk	0.001	0.999	0.000
F10.8 Other mental and behavioural disorders	0.000	0.999	0.001
F31.9 Bipolar affective disorder, unspecified	0.001	0.999	0.000
G02.0 Meningitis in viral diseases classified elsewhere	0.001	0.999	0.000
I22.1 Subsequent myocardial infarction of inferior wall	0.000	0.999	0.001
L50.9 Urticaria, unspecified	0.000	0.999	0.001
N05.2 Diffuse membranous glomerulonephritis	0.001	0.999	0.000
S06.3 Focal brain injury	0.000	0.999	0.001
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.999	0.001
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.999	0.001
T48.4 Expectorants	0.000	0.999	0.001
T48.3 Antitussives	0.000	0.999	0.001
T48.2 Other and unspecified agents primarily acting on muscles	0.000	0.999	0.001
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.999	0.001
T48.0 Oxytocic drugs	0.000	0.999	0.001
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.999	0.001
B17.8 Other specified acute viral hepatitis	0.000	0.999	0.001
M24.5 Contracture of joint	0.001	0.999	0.000
T93.8 Sequelae of other specified injuries of lower limb	0.001	0.999	0.000
G02 Meningitis in other infectious and parasitic diseases classified elsewhere	0.001	0.999	0.000
T36 Poisoning by systemic antibiotics	0.000	0.999	0.001
F10-F19 Mental and behavioural disorders due to psychoactive substance use	0.000	0.999	0.001
B17.1 Acute hepatitis C	0.000	0.999	0.001
F19.1 Harmful use	0.000	0.999	0.001
G03.9 Meningitis, unspecified	0.001	0.999	0.000
G04.8 Other encephalitis, myelitis and encephalomyelitis	0.001	0.999	0.000
O12.0 Gestational oedema	0.000	0.999	0.001
T38.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.999	0.001
T41.5 Therapeutic gases	0.000	0.999	0.001
T41.4 Anaesthetic, unspecified	0.000	0.999	0.001
T41.3 Local anaesthetics	0.000	0.999	0.001
T41.1 Intravenous anaesthetics	0.000	0.999	0.001
T41.0 Inhaled anaesthetics	0.000	0.999	0.001
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.999	0.001
T46.7 Peripheral vasodilators	0.000	0.999	0.001
Y83.9 Surgical procedure, unspecified	0.000	0.999	0.001
B17 Other acute viral hepatitis	0.000	0.999	0.001
G05 Encephalitis, myelitis and encephalomyelitis in diseases classified elsewhere	0.001	0.999	0.000
G03 Meningitis due to other and unspecified causes	0.001	0.999	0.000
G01 Meningitis in bacterial diseases classified elsewhere	0.001	0.999	0.000
G00-G09 Inflammatory diseases of the central nervous system	0.001	0.999	0.000
M05.92 Seropositive rheumatoid arthritis, unspecified (Upper arm)	0.000	0.999	0.001
F15.1 Harmful use	0.000	0.999	0.001
G05.1 Encephalitis, myelitis and encephalomyelitis in viral diseases classified elsewhere	0.001	0.999	0.000
G06.0 Intracranial abscess and granuloma	0.001	0.999	0.000
N05.1 Focal and segmental glomerular lesions	0.001	0.999	0.000
O34.2 Maternal care due to uterine scar from previous surgery	0.000	0.999	0.001
T46.3 Coronary vasodilators, not elsewhere classified	0.000	0.999	0.001
M24.87 Other specific joint derangements, not elsewhere classified (Ankle and foot)	0.001	0.999	0.000
M79.59 Residual foreign body in soft tissue (Site unspecified)	0.000	0.999	0.001
M79.55 Residual foreign body in soft tissue (Pelvic region and thigh)	0.000	0.999	0.001
M79.52 Residual foreign body in soft tissue (Upper arm)	0.000	0.999	0.001
M79.51 Residual foreign body in soft tissue (Shoulder region)	0.000	0.999	0.001
M79.50 Residual foreign body in soft tissue (Multiple sites)	0.000	0.999	0.001
M79.63 Pain in limb (Forearm)	0.000	0.999	0.001
S06.31 Focal brain injury (with open intracranial wound)	0.000	0.999	0.001
D33.3 Cranial nerves	0.000	0.999	0.001
D36.7 Other specified sites	0.001	0.999	0.000
F19.9 Unspecified mental and behavioural disorder	0.000	0.999	0.001
F19.8 Other mental and behavioural disorders	0.000	0.999	0.001
F19.7 Residual and late-onset psychotic disorder	0.000	0.999	0.001
F19.6 Amnesic syndrome	0.000	0.999	0.001
F19.4 Withdrawal state with delirium	0.000	0.999	0.001
F19.0 Acute intoxication	0.000	0.999	0.001
I60.3 Subarachnoid haemorrhage from posterior communicating artery	0.000	0.999	0.001
L50.8 Other urticaria	0.000	0.999	0.001
O32.8 Maternal care for other malpresentation of foetus	0.000	0.999	0.001
O80.1 Spontaneous breech delivery	0.000	0.999	0.001
S83.7 Injury to multiple structures of knee	0.001	0.999	0.000
T36.4 Tetracyclines	0.000	0.999	0.001
T45.2 Vitamins, not elsewhere classified	0.000	0.999	0.001
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.999	0.001
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.999	0.001
T48.6 Antiasthmatics, not elsewhere classified	0.000	0.999	0.001
T91.1 Sequelae of fracture of spine	0.001	0.999	0.000
F15 Mental and behavioural disorders due to use of other stimulants, including caffeine	0.000	0.999	0.001
M24.59 Contracture of joint (Site unspecified)	0.001	0.999	0.000
M24.58 Contracture of joint (Other)	0.001	0.999	0.000
M24.57 Contracture of joint (Ankle and foot)	0.001	0.999	0.000
M24.53 Contracture of joint (Forearm)	0.001	0.999	0.000
M24.50 Contracture of joint (Multiple sites)	0.001	0.999	0.000
M79.10 Myalgia (Multiple sites)	0.001	0.999	0.000
E10.9 Without complications	0.000	0.999	0.001
F19.3 Withdrawal state	0.000	0.999	0.001
G02.8 Meningitis in other specified infectious and parasitic diseases classified elsewhere	0.001	0.999	0.000
G02.1 Meningitis in mycoses	0.001	0.999	0.000
G05.0 Encephalitis, myelitis and encephalomyelitis in bacterial diseases classified elsewhere	0.001	0.999	0.000
T36.9 Systemic antibiotic, unspecified	0.000	0.999	0.001
T36.7 Antifungal antibiotics, systemically used	0.000	0.999	0.001
T36.6 Rifamycins	0.000	0.999	0.001
T36.5 Aminoglycosides	0.000	0.999	0.001
T36.3 Macrolides	0.000	0.999	0.001
T36.2 Chloramphenicol group	0.000	0.999	0.001
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.999	0.001
T37.5 Antiviral drugs	0.000	0.999	0.001
T37.4 Anthelminthics	0.000	0.999	0.001
T37.3 Other antiprotozoal drugs	0.000	0.999	0.001
T37.1 Antimycobacterial drugs	0.000	0.999	0.001
T37.0 Sulphonamides	0.000	0.999	0.001
T41.2 Other and unspecified general anaesthetics	0.000	0.999	0.001
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.999	0.001
F18 Mental and behavioural disorders due to use of volatile solvents	0.000	0.999	0.001
F16 Mental and behavioural disorders due to use of hallucinogens	0.000	0.999	0.001
F14 Mental and behavioural disorders due to use of cocaine	0.000	0.999	0.001
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.999	0.001
B17.0 Acute delta-(super) infection of hepatitis B carrier	0.000	0.999	0.001
F14.2 Dependence syndrome	0.000	0.999	0.001
F19.5 Psychotic disorder	0.000	0.999	0.001
G03.8 Meningitis due to other specified causes	0.001	0.999	0.000
G03.2 Benign recurrent meningitis [Mollaret]	0.001	0.999	0.000
G03.1 Chronic meningitis	0.001	0.999	0.000
G03.0 Nonpyogenic meningitis	0.001	0.999	0.000
G05.8 Encephalitis, myelitis and encephalomyelitis in other diseases classified elsewhere	0.001	0.999	0.000
G05.2 Encephalitis, myelitis and encephalomyelitis in other infectious and parasitic diseases classified elsewhere	0.001	0.999	0.000
O32.6 Maternal care for compound presentation	0.000	0.999	0.001
S83.6 Sprain and strain of other and unspecified parts of knee	0.001	0.999	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.000	0.999	0.001
T37.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.999	0.001

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations